ISPOR Europe 2019 Convened More Than 5500 Healthcare Stakeholders in the Society’s Largest Conference To Date

Published Nov 7, 2019

The Digital Transformation of Healthcare Was the Conference Focus

Copenhagen, Denmark—7 November 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), concluded its ISPOR Europe 2019 conference yesterday in Copenhagen, Denmark. The conference convened more than 5500 global healthcare stakeholders and HEOR thought leaders representing more than 90 countries from all sectors of healthcare, including researchers and academicians, assessors and regulators, payers and policymakers, the life sciences industry, healthcare providers, and patient engagement organizations. The record attendance of ISPOR Europe 2019 marks the Society’s largest conference to date.

ISPOR Europe 2019 Concludes

The conference opened with the first plenary session the morning of 4 November, “Healthcare Digitalization: Instant, On Demand, and Always Connected.” New technologies are driving change in healthcare systems; influencing the way diseases are prevented, diagnosed, and treated. This panel explored the issue of digitizing healthcare and how this is impacting healthcare and health systems globally.

The second plenary session, “Shaping the Digital Healthcare System,” was held 5 November. Healthcare is changing rapidly with this transformation impacting every area of the healthcare system, including its structures, processes, policies, and practices. This panel examined how those working in healthcare are adapting to these unprecedented technological developments to deliver more productive, effective, and personal care for patients.

The third plenary session, “Big Healthcare Data: Endless Opportunities for Research and Learning,” was the final plenary and held on 6 November. Big data present a tremendous opportunity for the measurement and reporting of quality in healthcare that can enhance insight and decision making. In this session, panelists discussed a number of examples where experts are effectively using big data for research and to drive learning at the healthcare system level.

ISPOR Europe 2019 also featured a variety of sessions on compelling topics, including the evaluation of digital health technologies, drug pricing, improving high-value care through increasing healthcare systems’ efficiency, real-world evidence (RWE) and the RWE Transparency Initiative, medical device evidence development, and the subscription-based model for drug reimbursement. The conference also held a variety of spotlight and featured sessions, including the new ISPOR Ideas Lab—an interactive session that explored fresh perspectives and new insights to improve healthcare decision making at system level.

ISPOR CEO and Executive Director Nancy S. Berg stated, “ISPOR Europe 2019 featured many innovative sessions centering on healthcare transformation fueled by digital technologies. ISPOR’s largest conference to date (with more than 5500 registrants) convened a wide variety of healthcare stakeholders to help solve many of the challenges that impact healthcare and to advance HEOR excellence to improve healthcare decisions globally.”

ISPOR is recognized globally as the leading professional society for health economics and outcomes research and its role in improving healthcare decisions. ISPOR Europe 2019 expects to draw more than 5500 healthcare stakeholders with an interest in HEOR, including researchers and academicians, assessors and regulators, payers and policymakers, the life sciences industry, healthcare providers, and patient engagement organizations.

Additional information on the conference can be found at:
Conference Information | Program and Presentations | #ISPOREurope | Sponsors | Exhibitors | News and Press

###

 

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg

Related Stories

Big Data Offer Opportunity for Research and Learning in Healthcare

Nov 6, 2019

ISPOR its third plenary session at ISPOR Europe 2019, “Big Data Healthcare: Endless Opportunities for Research and Learning," this morning in Copenhagen, Denmark.

Is the Subscription-Based Model for Drug Reimbursement the Future?

Nov 6, 2019

ISPOR explored the topical issue of the subscription-based model for drug reimbursement this morning during the session, “Subscription-Based Model for Drug Reimbursement: A Fad or the Future?”, at ISPOR Europe 2019 in Copenhagen, Denmark.

Bridging the Gap Between Evidence Requirements for Medical Device and Coverage/Reimbursement Decisions

Nov 5, 2019

ISPOR explored the issue of medical devices and the evolving demands for evidence requirements and assessments in the session, “The Evolving Demands for Medical Device Evidence Development: What the Future Holds.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×